Effect of intravenous ferric derisomaltose on outcomes in heart failure with or without ischaemic heart disease in the IRONMAN trial.
14 May 2024 (09:53 - 10:02)
Organised by: 
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
6 More presentations in this session
Miss B. Goovaerts (Antwerp, BE)
Assistant Professor P. Becher (Hamburg, DE)
Doctor M. Davies (The Woodlands, US)
Doctor D. Garcia Vega (Ourense, ES)
Access the full session
The Event
Heart Failure 2024
14 May 2024
09:53 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
